NFE2L2 and glioblastoma: Therefore, understanding the interaction among CYBB, NRF2, and SOD2, which were markedly active in mesenchymal GBM, can explain the orchestration of pro-oxidative and antioxidative regulation that underlies treatment resistance in mesenchymal GBM.